I get a great blessing from sitting at the bedside of the sickest of the sick and making sure to see them as human beings, not just an illness.” ...

MSK cellular therapist Dr. Heather Landau led a phase 1 clinical trial showing CAR T cell therapy is effective against relapsed or resistant AL amyloidosis. “I’ve seen very sick patients have an ...

MSK patient Cynthia Malaran — aka DJ CherishTheLuv — performs at South Street Seaport, in New York City. She participated in a clinical trial that studied the benefits of music therapy for ...

A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...

A new study leveraged data from the MSK-IMPACT tumor sequencing test to learn about the genetic complexity of cancer metastasis. When cancer spreads from a primary tumor to new sites throughout the ...

Beatriz Sawaya came to MSK from Brazil to receive a new treatment for resistant breast cancer as part of a clinical trial. The therapy has kept her cancer under control for more than five years and ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Close collaborations between the ID Service and the Bone Marrow Transplant, Leukemia, and Melanoma Services at MSK have demonstrated the impact that a patient’s microbiome can have on the outcome of ...

A team of doctors and researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked ...

Research at MSK Our research impact Research topics Core facilities & resources ...